Connolly Sarah T. Abbott Laboratories Transaction History

Connolly Sarah T.

$1.11 Billion
Q4 2023

A detailed history of Connolly Sarah T. transactions in Abbott Laboratories stock. As of the latest transaction made, Connolly Sarah T. holds 1,825 shares of ABT stock, worth $190,201. This represents 18.14% of its overall portfolio holdings.

Number of Shares

1,825

Previous 16,975 89.25%

Holding current value

$190,201

Previous $1.64 Million 12118.86%

% of portfolio

18.14%

Previous 1.1%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $1.37 Million - $1.67 Million	-15,150 Reduced 89.25%	1,825 $201 Million
Q3 2023 Oct 23, 2023	SELL	$95.53 - $114.62 $57,318 - $68,772	-600 Reduced 3.41%	16,975 $1.64 Million
Q2 2023 Jul 27, 2023	SELL	$100.78 - $112.29 $2,015 - $2,245	-20 Reduced 0.11%	17,575 $1.92 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $43,587 - $51,304	-450 Reduced 2.49%	17,595 $1.78 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $12,357 - $14,497	-130 Reduced 0.72%	18,045 $1.98 Million

Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $45,477 - $52,654	-470 Reduced 2.52%	18,175 $1.76 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $19,903 - $24,057	195 Added 1.06%	18,645 $2.03 Million
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $54,876 - $67,193	475 Added 2.64%	18,450 $2.6 Million
Q2 2021 Jul 14, 2021	BUY	$105.79 - $124.53 $21,686 - $25,528	205 Added 1.15%	17,975 $2.08 Million
Q1 2021 Apr 26, 2021	SELL	$108.84 - $128.23 $6,530 - $7,693	-60 Reduced 0.34%	17,770 $2.13 Million
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $1.87 Million - $2.04 Million	17,830 New	17,830 $1.95 Million

Others Institutions Holding ABT

# of Institutions

3,133

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.69M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $183B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connolly Sarah T., based on Form 13F filings with the SEC.

News

Stay updated on Connolly Sarah T. with notifications on news.

Account